Climb Bio, Inc. — Form D

Climb Bio, Inc. of WELLESLEY HILLS, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-02. The offering totals $120.0M, of which $120.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Aoife BrennanDirectorWellesley Hills, MA
Judith DunnDirectorWellesley Hills, MA
Andrew LevinDirectorBOSTON, MA
Liam RatcliffeDirectorNew York, NY
Adam RosenbergDirectorWilmington, DE
Simon TateDirectorWilmington, DE
Stephen ThomasDirectorDallas, TX
Aoife BrennanExecutive OfficerWellesley Hills, MA
Andrew LevinExecutive OfficerBOSTON, MA
Valerie MorissetExecutive OfficerWilmington, DE
Andrew LevinRelated PersonBOSTON, MA
Stephen ThomasRelated PersonDallas, TX
Julio VegaExecutive OfficerCambridge, MA
Erin LavelleExecutive OfficerCharlottesville, VA
Aoife BrennanRelated PersonWellesley Hills, MA
Judith DunnRelated PersonWellesley Hills, MA
David-Alexandre GrosDirectorIrvine, CA
Douglas WilliamsRelated PersonWellesley Hills, MA
Robert AzelbyDirectorRedmond, WA
Robert AzelbyExecutive OfficerRedmond, WA
James BucherExecutive OfficerRedmond, WA
Leone PattersonDirectorRedmond, WA
Harald StockDirectorPark City, UT
Susan AltschullerRelated PersonWellesley Hills, MA
Perrin WilsonRelated PersonWellesley Hills, MA

Other filings by this issuer (7)

FiledFormOfferingSold
2026-05-04D$110.1M$110.1M
2024-07-02D$41.9M$41.9M
2021-05-28D$60.0M$60.0M
2020-11-03D$50.0M$5.0M
2019-10-23D$10.0M$10.0M
2019-10-23D/A$16.3M$16.3M
2019-02-19D$12.2M$12.2M

More